Asset Allocation

As of July 31, 2026.
Type % Net
Cash 0.16%
Stock 68.44%
Bond 26.37%
Convertible 0.00%
Preferred 0.00%
Other 5.03%
View Asset Allocation
Start Trial

Market Capitalization

As of July 31, 2026
Large 74.86%
Mid 16.49%
Small 8.65%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 92.38%    % Emerging Markets: 0.22%    % Unidentified Markets: 7.40%

Americas 85.49%
84.35%
Canada 0.86%
United States 83.49%
1.15%
As of July 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 5.55%
United Kingdom 1.12%
4.43%
Belgium 0.37%
Finland 0.12%
France 0.05%
Germany 0.02%
Ireland 0.79%
Italy 0.06%
Netherlands 1.00%
Sweden 0.21%
Switzerland 1.11%
0.00%
0.00%
Greater Asia 1.55%
Japan 0.09%
0.30%
Australia 0.30%
1.14%
Hong Kong 0.03%
Singapore 0.32%
Taiwan 0.79%
0.03%
China 0.02%
Unidentified Region 7.40%

Bond Credit Quality Exposure

AAA 9.76%
AA 55.92%
A 7.03%
BBB 14.44%
BB 0.02%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.28%
Not Available 12.54%
Short Term 0.00%
As of July 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
24.07%
Materials
4.55%
Consumer Discretionary
7.87%
Financials
10.44%
Real Estate
1.21%
Sensitive
54.73%
Communication Services
6.62%
Energy
4.05%
Industrials
12.05%
Information Technology
32.02%
Defensive
12.70%
Consumer Staples
1.48%
Health Care
9.92%
Utilities
1.31%
Not Classified
3.34%
Non Classified Equity
3.34%
As of July 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of July 31, 2026
Type % Net
Government 50.76%
Corporate 20.14%
Securitized 29.03%
Municipal 0.06%
Other 0.01%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
2.39%
Less than 1 Year
2.39%
Intermediate
56.18%
1 to 3 Years
4.73%
3 to 5 Years
13.60%
5 to 10 Years
37.84%
Long Term
41.37%
10 to 20 Years
14.06%
20 to 30 Years
22.91%
Over 30 Years
4.40%
Other
0.06%
As of July 31, 2026
View Bond Maturity Exposure
Start Trial